X0306 4 2015-02-21 1 0000890465 NPS PHARMACEUTICALS INC NPSP 0001256088 GEMAYEL GEORGES 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Common Stock 2015-02-21 4 U 0 9000 46.00 D 0 D Stock Options (right to buy) 6.95 2015-02-21 4 D 0 56500 D 2022-02-28 Common Stock 56500 0 D Restricted Stock Units 2015-02-21 4 D 0 3816 D Common Stock 3816 0 D Deferred Stock Units 2015-02-21 4 D 0 5624 D Common Stock 5624 0 D On February 28, 2012, the stock options were granted with one fourth vesting on the first anniversary of date of grant and 6.25% vesting every three months thereafter. In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. (the "Issuer") on February 21, 2015, each outstanding stock option, whether vested or unvested, was cancelled in exchange for a single lump sum cash payment in an amount equal to the product of (1) the number of shares of the Issuer's common stock subject to such stock option and (2) the execess, if any, of $46.00 over the exercise price per share of such stock option. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. On February 12, 2015, the Restricted Stock Units were granted with one hundred percent vesting on the first anniversary of date of grant. In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. on February 21, 2015, each outstanding Restricted Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Restricted Stock Unit. Each Deferred Stock Unit represents a right to receive one share of the Issuer's common stock. Deferred Stock Units are vested in full on the date of grant and will be settled in the Issuer's common stock upon (1) separation from service on the Board, (2) death, (3) disability or (4) a sale of substantially all the assets of the Issuer. In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. on February 21, 2015, each outstanding Deferred Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Deferred Stock Unit. /s/ Georges Gemayel, by Jill Thompson as attorney-in-fact 2015-02-24